NCT06602271View on ClinicalTrials.gov

PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions
Postoperative PainPostoperative Pain, Acute
Interventions
DRUG

PF614 capsule

Experimental oxycodone prodrug

DRUG

Placebo

Inactive medication

DRUG

Oxycodone HCl 10 mg

Active comparator

Sponsors
All Listed Sponsors
lead

Ensysce Biosciences

INDUSTRY